Acanthamoeba Keratitis
- 1 September 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 106 (9), 1196-1201
- https://doi.org/10.1001/archopht.1988.01060140356031
Abstract
• Clotrimazole is an antifungal agent that has been shown to have excellent in vitro activity against most strains of Acanthamoeba. We encountered four patients who developed Acanthamoeba keratitis while wearing contact lenses that had been stored in homemade saline. Their medical treatment regimens included the use of topical 1% clotrimazole. In two patients in whom conventional therapy failed, clotrimazole was successful in controlling recurrent infection following penetrating keratoplasty. Two other patients were treated with clotrimazole as well as propamidine isethionate and neomycin sulfate-polymyxin B sulfate-gramicidin from the outset, and had an excellent response to medical therapy. In those patients who found the commercially available cream uncomfortable, a 1% clotrimazole suspension formulated in artificial tears was used and found to be well tolerated.This publication has 7 references indexed in Scilit:
- Clinical Signs and Medical Therapy of Early Acanthamoeba KeratitisArchives of Ophthalmology (1950), 1988
- Acanthamoeba keratitis in soft contact lens wearers. A case-control studyJAMA, 1987
- Medical and Surgical Treatment of Acanthamoeba KeratitisAmerican Journal of Ophthalmology, 1987
- Ocular toxicity of topical clotrimazole preparationsJournal of Toxicology- Cutaneous and Ocular Toxicology, 1987
- Acanthamoeba keratitis successfully treated medically.British Journal of Ophthalmology, 1985
- Drug sensitivity and resistance of four Acanthamoeba speciesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1980
- Chemotherapeutic compounds and Acanthamoebae from eye infections.Journal of Clinical Pathology, 1976